Merit Medical Systems (MMSI) said Tuesday it has bought Biolife Delaware for about $120 million.
The acquisition will likely add about $18 million of revenue on an annualized basis starting in fiscal 2026, with a mid-teens growth and accretive non-GAAP margin and profitability profile, Merit Medical Systems said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.